//
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Nitrosative stress drives heart failure with preserved ejection fraction
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification